WETS
WST icon

Wealth Enhancement Trust Services’s West Pharmaceutical WST Stock Holding History

Wealth Enhancement Trust Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59K Buy
+10
New +$3.06K ﹤0.01% 900

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wealth Enhancement Trust Services's WST Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in West Pharmaceutical (WST) in Q2 2026: 10 shares worth $3.59K. The stake represents ﹤0.01% of the portfolio and ranks #900 among its holdings.

653 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Wealth Enhancement Trust Services held 10 shares of West Pharmaceutical worth $3.59K as of Q2 2026.
  • West Pharmaceutical was a new Wealth Enhancement Trust Services position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #900 holding.
  • 653 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.